New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
07:04 EDTCASICASI Pharmaceuticals' receives approval from CFDA to conduct clinical trial
CASI Pharmaceuticals announced that China's Food and Drug Administration, or CFDA has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer patients in China for its proprietary drug candidate, ENMD-2076.
News For CASI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 20, 2015
07:05 EDTCASICASI Pharmaceuticals announces Zevalin is now available at Hong Kong hospitals
CASI Pharmaceuticals announces that ZEVALIN is now available at hospitals in Hong Kong to patients with indicated non-Hodgkin's lymphoma, or NHL, including at Hong Kong Sanatorium & Hospital. The drug will be supplied by CASI and its local partner, Global Medical Solutions Hong Kong Limited.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use